As one of the great popular actors of our time, Harrison Ford, is much admired by filmgoers in Taiwan and overseas. However, in a Ford-produced movie that sees him playing the role of a Midwestern medical researcher looking for a cure for a rare muscle disease, released earlier this year in theaters in the US and now worldwide on DVD, titled Extraordinary Measures, Ford neglected to give credit to the actual scientist who found the cure for Pompe Disease — Chen Yuan-tsong (陳垣崇) of Taiwan.
Chen did the original research that led to finding the cure in the 1990s while he was at Duke University in North Carolina. A writer for the Wall Street Journal, Geeta Annand, wrote a series of newspaper articles about the search for the cure and later turned her stories into a book titled The Cure.
Ford bought the film rights to the book, asked his scriptwriters to turn Chen into a white lab scientist named Dr Stonehill and completely left any mention of Chen’s work out of the picture. Not one part of the movie’s dialog mentions Chen’s name at all and even the opening and closing credits fail to mention the doctor’s name.
Ford and the Hollywood studio that bankrolled the movie need to explain themselves. Sure, movies are movies and Hollywood is Hollywood, but to take the real-life medical work of a Taiwanese scientist and turn it into a Hollywood medical thriller “inspired by true events” that does even mention the name of the man who inspired the movie is an affront to medical researchers everywhere.
When Chen recently attended a press conference on the sidelines of the release of the DVD version of the movie, the Central News Agency (CNA) in Taipei reported that he had “mixed feelings” about the movie.
When this reporter recently asked Chen to explain his feelings about the movie, he told me: “What the movie failed to show was who actually developed the drug that the characters Megan and Patrick in the film eventually received. There were many scientists behind the scenes that helped to find the cure.”
However, Chen was gracious in his remarks, adding: “However, I still appreciate Harrison Ford bringing the Pompe story to movie audiences worldwide. This kind of Hollywoodized medical drama helps create public awareness of rare devastating diseases such as Pompe, and hopefully the film will create support channels for helping those children who suffer from Pompe and their families.”
Despite Hollywood’s neglect, Chen is now being recognized in Taiwan for his medical research on Pompe Disease.
“Regardless of how Hollywood decided to recast Chen, his contribution to helping find the cure is well established,” CNA said. “He developed the treatment with colleagues at Duke University Medical Center. His R&D was mostly done in the United States, but Chen conducted his clinical trials for the cure — later named Myozyme — in Taiwan, at National Taiwan University Hospital.”
“Myozyme, which took Chen and his team 15 years to research and develop, was introduced in Taiwan by US pharmaceutical company Genzyme and included as a drug covered by Taiwan’s National Health Insurance program in 2005. Myozyme was sold in Europe and the United States after it was approved by the US government and the European Union health authority in 2006,” CNA said.
Chen’s work has resulted in saving over a thousand lives of those with Pompe Disease worldwide — also known as “acid maltase deficiency” — including 34 children in Taiwan, the CNA said.
However, not one bit of dialogue in the movie or one small note of thanks in the film’s opening or closing credits mention Chen’s name at all. He has been airbrushed out of the story, whitewashed out of the way by Hollywood moguls. Not a pretty picture.
And yet the movie itself, as Chen so graciously said, is a good one and an important one. I saw the movie the other day on a rented DVD and I agree with Chen — the film serves an important purpose in educating the public, and Ford plays his role well.
Dan Bloom is a US writer based in Taiwan.
A foreign colleague of mine asked me recently, “What is a safe distance from potential People’s Liberation Army (PLA) Rocket Force’s (PLARF) Taiwan targets?” This article will answer this question and help people living in Taiwan have a deeper understanding of the threat. Why is it important to understand PLA/PLARF targeting strategy? According to RAND analysis, the PLA’s “systems destruction warfare” focuses on crippling an adversary’s operational system by targeting its networks, especially leadership, command and control (C2) nodes, sensors, and information hubs. Admiral Samuel Paparo, commander of US Indo-Pacific Command, noted in his 15 May 2025 Sedona Forum keynote speech that, as
Chinese Nationalist Party (KMT) Chairman Eric Chu (朱立倫) last week announced that the KMT was launching “Operation Patriot” in response to an unprecedented massive campaign to recall 31 KMT legislators. However, his action has also raised questions and doubts: Are these so-called “patriots” pledging allegiance to the country or to the party? While all KMT-proposed campaigns to recall Democratic Progressive Party (DPP) lawmakers have failed, and a growing number of local KMT chapter personnel have been indicted for allegedly forging petition signatures, media reports said that at least 26 recall motions against KMT legislators have passed the second signature threshold
The Central Election Commission (CEC) on Friday announced that recall motions targeting 24 Chinese Nationalist Party (KMT) lawmakers and Hsinchu Mayor Ann Kao (高虹安) have been approved, and that a recall vote would take place on July 26. Of the recall motions against 35 KMT legislators, 31 were reviewed by the CEC after they exceeded the second-phase signature thresholds. Twenty-four were approved, five were asked to submit additional signatures to make up for invalid ones and two are still being reviewed. The mass recall vote targeting so many lawmakers at once is unprecedented in Taiwan’s political history. If the KMT loses more
Taiwan’s unconditional support “for all legitimate and necessary actions taken by the government of India to safeguard national security and fight terrorist forces that cross borders to attack innocent civilians” marked a monumental shift in the relationship between Taipei and New Delhi. At a time when the Indian government sent several delegations of parliament members to convey to the rest of the world Pakistan’s role in sponsoring terrorism against India, Taiwan became one of the few nations that unequivocally supported India’s military operation, “Sindhoor.” Sure, this change in bilateral ties did not happen in a vacuum. Over the past decade,
RSS